Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review
Abstract There is increasing evidence that cannabidiol (CBD) use is associated with clinically significant liver enzyme (LE) elevations and drug‐induced…
Michael Boivin
Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
Abstract Background: One in five individuals live with chronic pain globally, which often co-occurs with sleep problems, anxiety, depression, and…
A Clinical Framework for Evaluating Cannabis Product Quality and Safety
Abstract Increase in medical cannabis use, along with available products, warrants the need for clinicians to be knowledgeable in evaluating…
A Clinical Framework for Assessing Cannabis-Related Impairment Risk
Abstract Clinicians play an important role in promoting safe and responsible medical cannabis use. One essential component to safe use…
Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
Abstract Background: Globally, medical cannabis legalization has increased in recent years and medical cannabis is commonly used to treat chronic…
Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain
Abstract Background: Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult population. Current United States and Canadian…